These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 29656404)

  • 1. Pyoderma gangrenosum in an infant: A case report and review of the literature.
    Crouse L; McShane D; Morrell DS; Wu EY
    Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infliximab for a girl with refractory pyoderma gangrenosum].
    Nozawa T; Hara R; Kinoshita J; Sano F; Miyamae T; Imagawa T; Mori M; Hirokado M; Takahashi K; Inayama Y; Yokota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):454-9. PubMed ID: 19122376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of refractory pyoderma gangrenosum with infliximab in a 17-month-old boy.
    Bobbitt SA; Klaus EM; Stringer E; Chowdhury D; Finlayson L
    Dermatol Online J; 2016 Apr; 22(4):. PubMed ID: 27617462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum following breast reduction: treatment with topical tacrolimus and steroids.
    Doren EL; Aya-ay ML
    Aesthet Surg J; 2014 Mar; 34(3):394-9. PubMed ID: 24448967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical tacrolimus therapy for pyoderma gangrenosum.
    Chiba T; Isomura I; Suzuki A; Morita A
    J Dermatol; 2005 Mar; 32(3):199-203. PubMed ID: 15863867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory pyoderma gangrenosum treated with infliximab in an infant.
    Campos-Muñoz L; Conde-Taboada A; Aleo E; Toledano E; López-Bran E
    Clin Exp Dermatol; 2014 Apr; 39(3):336-9. PubMed ID: 24635074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of refractory pyoderma gangrenosum treated with a combination of Apligraf and systemic immunosuppressive agents.
    Duchini G; Itin P; Arnold A
    Adv Skin Wound Care; 2011 May; 24(5):217-20. PubMed ID: 21505282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone.
    Staub J; Pfannschmidt N; Strohal R; Braun-Falco M; Lohse P; Goerdt S; Leverkus M
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2243-7. PubMed ID: 25352307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
    Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
    Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of vulvar pyoderma gangrenosum associated with collagenous colitis.
    Roé E; Dalmau J; García-Navarro X; Corella F; Monfort D; Busquets D; Ribé A; Delgado E; Alomar A
    Dermatology; 2006; 213(3):234-5. PubMed ID: 17033174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Efficacy of Topical Dapsone Treatment for Pyoderma Gangrenosum: A Retrospective Case Series.
    Li DG; Din RS; Tsiaras WG; Mostaghimi A
    J Cutan Med Surg; 2018; 22(6):650-651. PubMed ID: 30322308
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of pyoderma gangrenosum with methotrexate.
    Teitel AD
    Cutis; 1996 May; 57(5):326-8. PubMed ID: 8726713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab is an appropriate second-line therapy in infants with steroid refractory pyoderma gangrenosum.
    Lesmeister LM; Peitz J; von Kleist-Retzow JC; Lee-Kirsch MA; Torrelo A; Tantcheva-Poor I; Broekaert IJ
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):e376-e378. PubMed ID: 35037304
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic pyoderma gangrenosum responding to infliximab and adalimumab.
    Hubbard VG; Friedmann AC; Goldsmith P
    Br J Dermatol; 2005 May; 152(5):1059-61. PubMed ID: 15888172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful therapy of refractory pyoderma gangrenosum and periorbital phlegmona with tacrolimus (FK506) in ulcerative colitis.
    Baumgart DC; Wiedenmann B; Dignass AU
    Inflamm Bowel Dis; 2004 Jul; 10(4):421-4. PubMed ID: 15475751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case Series of 4 Patients With Peristomal Pyoderma Gangrenosum: Review of Risk Factors and Treatment Response.
    Turrión-Merino L; Hermosa-Zarza E; Miguel L; Muñoz-Zato E
    Actas Dermosifiliogr; 2016 Apr; 107(3):e13-7. PubMed ID: 26626501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pyoderma gangrenosum: successful topical therapy with tacrolimus (FK506)].
    Petering H; Kiehl P; Breuer C; Kapp A; Werfel T
    Hautarzt; 2001 Jan; 52(1):47-50. PubMed ID: 11220239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic absorption of topical tacrolimus in Pyoderma gangrenosum.
    Pitarch G; Torrijos A; Mahiques L; Sánchez-Carazo JL; Fortea JM
    Acta Derm Venereol; 2006; 86(1):64-5. PubMed ID: 16585995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.